Amphotericin B: current understanding of mechanisms of action.
作者信息
Brajtburg J, Powderly W G, Kobayashi G S, Medoff G
机构信息
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.
出版信息
Antimicrob Agents Chemother. 1990 Feb;34(2):183-8. doi: 10.1128/AAC.34.2.183.
Abstract
摘要
相似文献
1
Amphotericin B: current understanding of mechanisms of action.
Antimicrob Agents Chemother. 1990 Feb;34(2):183-8. doi: 10.1128/AAC.34.2.183.
2
Use of amphotericin B with azole antifungal drugs: what are we doing?
Antimicrob Agents Chemother. 1995 Sep;39(9):1907-12. doi: 10.1128/AAC.39.9.1907.
3
Mechanisms and clinical impact of antifungal drug resistance.
J Med Vet Mycol. 1994;32 Suppl 1:189-202. doi: 10.1080/02681219480000821.
4
In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin B.
Antimicrob Agents Chemother. 1984 Mar;25(3):387-9. doi: 10.1128/AAC.25.3.387.
5
Comparative in vitro antifungal activity of amphotericin B and amphotericin B methyl ester.
Antimicrob Agents Chemother. 1975 Jan;7(1):58-63. doi: 10.1128/AAC.7.1.58.
6
The in-vitro activity of an antifungal antibiotic benanomicin A in comparison with amphotericin B.
J Antimicrob Chemother. 1996 Dec;38(6):1073-7. doi: 10.1093/jac/38.6.1073.
7
[Comparative clinical and bacteriological tests of amphocycline and tetracycline].
Bull Soc R Belge Gynecol Obstet. 1969;39(1):21-33.
8
Susceptibility of Allescheria boydii to amphotericin B.
Antimicrob Agents Chemother (Bethesda). 1968;8:429-30. doi: 10.1128/AAC.8.4.429.
9
Activity of nasal amphotericin B irrigation against fungal organisms in vitro.
Am J Rhinol. 2007 Mar-Apr;21(2):145-8. doi: 10.2500/ajr.2007.21.2988.
10
Susceptibility of zygomycetes to amphotericin B, miconazole, and ketoconazole.
Antimicrob Agents Chemother. 1981 Nov;20(5):688-90. doi: 10.1128/AAC.20.5.688.
引用本文的文献
1
Genome alteration of Leishmania orientalis under Amphotericin B inhibiting conditions.
PLoS Negl Trop Dis. 2024 Dec 17;18(12):e0012716. doi: 10.1371/journal.pntd.0012716. eCollection 2024 Dec.
2
Projecting phytochemical bacoside A anti-mucorale agent: An in-silico and in-vitro assessment.
Heliyon. 2024 Aug 22;10(16):e36553. doi: 10.1016/j.heliyon.2024.e36553. eCollection 2024 Aug 30.
3
Application and evaluation of topical amphotericin B for the treatment of respiratory fungal infections.
BMC Infect Dis. 2024 Apr 24;24(1):439. doi: 10.1186/s12879-024-09342-9.
4
Progress in the application of nanoparticles for the treatment of fungal infections: A review.
Mycology. 2023 Dec 8;15(1):1-16. doi: 10.1080/21501203.2023.2285764. eCollection 2024.
5
Anticandidal Activity of In Situ Methionine γ-Lyase-Based Thiosulfinate Generation System vs. Synthetic Thiosulfinates.
Pharmaceuticals (Basel). 2023 Dec 7;16(12):1695. doi: 10.3390/ph16121695.
6
Antimicrobial Peptide Synergies for Fighting Infectious Diseases.
Adv Sci (Weinh). 2023 Sep;10(26):e2300472. doi: 10.1002/advs.202300472. Epub 2023 Jul 5.
7
Repurposing Amphotericin B: anti-microbial, molecular docking and molecular dynamics simulation studies suggest inhibition potential of Amphotericin B against MRSA.
BMC Chem. 2023 Jun 29;17(1):67. doi: 10.1186/s13065-023-00980-9.
8
Recent Advances in Chemotherapeutics for Leishmaniasis: Importance of the Cellular Biochemistry of the Parasite and Its Molecular Interaction with the Host.
Pathogens. 2023 May 12;12(5):706. doi: 10.3390/pathogens12050706.
9
Chalcone Schiff bases disrupt cell membrane integrity of Saccharomyces cerevisiae and Candida albicans cells.
Arch Microbiol. 2023 May 20;205(6):246. doi: 10.1007/s00203-023-03584-y.
10
The antifungal effect induced by itraconazole in Candida parapsilosis largely depends on the oxidative stress generated at the mitochondria.
Curr Genet. 2023 Jun;69(2-3):165-173. doi: 10.1007/s00294-023-01269-z. Epub 2023 Apr 29.
本文引用的文献
1
DEVELOPMENT OF RESISTANCE TO POLYENE ANTIBIOTICS IN CANDIDA ALBICANS.
J Bacteriol. 1965 Jun;89(6):1533-9. doi: 10.1128/jb.89.6.1533-1539.1965.
2
Application of differential spectra in the ultraviolet-visible region to study the formation of amphotericin B-sterol complexes.
Biochim Biophys Acta. 1980 Nov 4;602(2):260-8. doi: 10.1016/0005-2736(80)90309-0.
3
Incidence of polyene-resistant yeasts recovered from clinical specimens.
Antimicrob Agents Chemother. 1980 Jul;18(1):158-63. doi: 10.1128/AAC.18.1.158.
4
Leukoencephalopathy in patients treated with amphotericin B methyl ester.
J Infect Dis. 1982 Aug;146(2):125-37. doi: 10.1093/infdis/146.2.125.
5
Differences in the interaction of the polyene antibiotic amphotericin B with cholesterol- or ergosterol-containing phospholipid vesicles. A circular dichroism and permeability study.
Biochemistry. 1983 Jun 7;22(12):2939-44. doi: 10.1021/bi00281a024.
6
Haemolytic activity of aromatic heptaenes. A group of polyene macrolide antifungal antibiotics.
Biochem Pharmacol. 1984 Jan 1;33(1):41-6. doi: 10.1016/0006-2952(84)90368-x.
7
Polyene toxicity in renal medulla: injury mediated by transport activity.
Science. 1984 Apr 6;224(4644):66-8. doi: 10.1126/science.6322305.
8
Stimulatory, permeabilizing, and toxic effects of amphotericin B on L cells.
Antimicrob Agents Chemother. 1984 Dec;26(6):892-7. doi: 10.1128/AAC.26.6.892.
9
The development of resistance by candida species to polyene antibiotics in vitro.
J Med Microbiol. 1971 Nov;4(4):505-17. doi: 10.1099/00222615-4-4-505.
10
Sterols from polyene-resistant mutants of Candida albicans.
J Gen Microbiol. 1972 Nov;73(1):201-3. doi: 10.1099/00221287-73-1-201.
Zotero 插件